Principal Financial Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.01M Sell
286,148
-6,684
-2% -$90.1K ﹤0.01% 1685
2025
Q4
$3.29M Buy
292,832
+21,574
+8% +$247K ﹤0.01% 1740
2025
Q3
$3.14M Buy
271,258
+11,718
+5% +$137K ﹤0.01% 1731
2025
Q2
$3.18M Buy
259,540
+15,477
+6% +$195K ﹤0.01% 1708
2025
Q1
$3.5M Buy
244,063
+6,269
+3% +$97.9K ﹤0.01% 1653
2024
Q4
$3.79M Buy
237,794
+7,932
+3% +$157K ﹤0.01% 1671
2024
Q3
$5.52M Sell
229,862
-16,382
-7% -$374K ﹤0.01% 1539
2024
Q2
$4.91M Sell
246,244
-10,570
-4% -$206K ﹤0.01% 1557
2024
Q1
$5.11M Buy
256,814
+3,550
+1% +$68.6K ﹤0.01% 1559
2023
Q4
$5.68M Sell
253,264
-6,503
-3% -$134K ﹤0.01% 1513
2023
Q3
$5.25M Sell
259,767
-10,079
-4% -$228K ﹤0.01% 1512
2023
Q2
$6.9M Sell
269,846
-16,654
-6% -$439K ﹤0.01% 1416
2023
Q1
$8.52M Sell
286,500
-4,358
-1% -$127K 0.01% 1336
2022
Q4
$7.87M Sell
290,858
-12,220
-4% -$299K 0.01% 1368
2022
Q3
$6.6M Sell
303,078
-23,987
-7% -$627K 0.01% 1392
2022
Q2
$8.94M Sell
327,065
-39,895
-11% -$1.15M 0.01% 1325
2022
Q1
$12.3M Sell
366,960
-22,006
-6% -$709K 0.01% 1259
2021
Q4
$13.5M Buy
388,966
+9,424
+2% +$305K 0.01% 1231
2021
Q3
$11.8M Sell
379,542
-11,719
-3% -$398K 0.01% 1309
2021
Q2
$14.2M Buy
391,261
+214,171
+121% +$8.86M 0.01% 1225
2021
Q1
$7.75M Buy
177,090
+28,392
+19% +$1.33M 0.01% 1507
2020
Q4
$6.82M Sell
148,698
-766
-0.5% -$31.9K 0.01% 1440
2020
Q3
$4.96M Sell
149,464
-4,484
-3% -$143K ﹤0.01% 1447
2020
Q2
$4.53M Buy
153,948
+3,993
+3% +$116K ﹤0.01% 1468
2020
Q1
$4.04M Sell
149,955
-61,544
-29% -$1.84M ﹤0.01% 1370
2019
Q4
$7.13M Buy
211,499
+7,400
+4% +$268K 0.01% 1406
2019
Q3
$7.65M Sell
204,099
-2,469
-1% -$94.2K 0.01% 1349
2019
Q2
$9.01M Sell
206,568
-15,449
-7% -$661K 0.01% 1283
2019
Q1
$9.48M Sell
222,017
-4,276
-2% -$191K 0.01% 1256
2018
Q4
$10.1M Sell
226,293
-11,699
-5% -$613K 0.01% 1172
2018
Q3
$16.3M Buy
237,992
+1,861
+0.8% +$120K 0.01% 999
2018
Q2
$13.5M Buy
236,131
+3,712
+2% +$196K 0.01% 1102
2018
Q1
$10.7M Buy
232,419
+6,411
+3% +$304K 0.01% 1213
2017
Q4
$10.4M Buy
226,008
+520
+0.2% +$23.9K 0.01% 1245
2017
Q3
$10.2M Buy
225,488
+1,527
+0.7% +$65.2K 0.01% 1227
2017
Q2
$8.8M Buy
223,961
+30,793
+16% +$1.16M 0.01% 1300
2017
Q1
$7.36M Buy
193,168
+4,141
+2% +$161K 0.01% 1374
2016
Q4
$6.99M Buy
189,027
+3,410
+2% +$122K 0.01% 1388
2016
Q3
$6.43M Buy
185,617
+9,811
+6% +$344K 0.01% 1364
2016
Q2
$5.72M Buy
175,806
+27,035
+18% +$828K 0.01% 1371
2016
Q1
$4.27M Buy
148,771
+830
+0.6% +$22.1K 0.01% 1436
2015
Q4
$4.94M Buy
147,941
+10,792
+8% +$336K 0.01% 1373
2015
Q3
$3.9M Sell
137,149
-2,720
-2% -$94.9K 0.01% 1446
2015
Q2
$5.66M Buy
139,869
+13,624
+11% +$611K 0.01% 1358
2015
Q1
$6.21M Sell
126,245
-767
-0.6% -$35.5K 0.01% 1274
2014
Q4
$5.78M Buy
+127,012
New +$4.99M 0.01% 1306

Other funds holding AVNS